Rwanda: Liberalizing Import of Malaria Drugs Without Strict Rules Is Suicidal

A new study by researchers from Fogarty International Center at the National Institutes of Health in the United States of America has revealed that a third of antimalarial drugs in South East Asia and sub-Saharan Africa are counterfeit.

As a result, more than 3.3 billion people risk of malaria in the 106 endemic countries may soon develop resistance to malaria drugs. That means that even the most effective drugs would no longer be able to cure the disease in such people. Therefore, the number of people who die every year from this tropical disease will inevitably shoot up. Yet already, about 1.2 million people die every year from malaria infection.

...

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.